These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8308935)

  • 1. Women opiate users' perceptions of treatment services in New York City.
    Hanke PJ; Faupel CE
    J Subst Abuse Treat; 1993; 10(6):513-22. PubMed ID: 8308935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The perceptions of program directors and clients regarding the efficacy of methadone treatment.
    Mavis BE; DeVoss GH; Stöffelmayr BE
    Int J Addict; 1991 Jul; 26(7):769-76. PubMed ID: 1660042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Client and counselor attitudes toward the use of medications for treatment of opioid dependence.
    Rieckmann T; Daley M; Fuller BE; Thomas CP; McCarty D
    J Subst Abuse Treat; 2007 Mar; 32(2):207-15. PubMed ID: 17306729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.
    Madden A; Lea T; Bath N; Winstock AR
    Drug Alcohol Rev; 2008 Nov; 27(6):671-8. PubMed ID: 19378450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs.
    Millson P; Challacombe L; Villeneuve PJ; Strike CJ; Fischer B; Myers T; Shore R; Hopkins S
    Eur Addict Res; 2006; 12(2):74-82. PubMed ID: 16543742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-perceived health among Canadian opiate users: a comparison to the general population and to other chronic disease populations.
    Millson PE; Challacombe L; Villeneuve PJ; Fischer B; Strike CJ; Myers T; Shore R; Hopkins S; Raftis S; Pearson M
    Can J Public Health; 2004; 95(2):99-103. PubMed ID: 15074898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based treatment for opiate-dependent clients: availability, variation, and organizational correlates.
    Ducharme LJ; Knudsen HK; Roman PM
    Am J Drug Alcohol Abuse; 2006; 32(4):569-76. PubMed ID: 17127545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Iranian women seeking drug treatment.
    Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Allsop D; Mokri A
    J Womens Health (Larchmt); 2011 Nov; 20(11):1687-91. PubMed ID: 21905877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Something of value: the introduction of contingency management interventions into the New York City Health and Hospital Addiction Treatment Service.
    Kellogg SH; Burns M; Coleman P; Stitzer M; Wale JB; Kreek MJ
    J Subst Abuse Treat; 2005 Jan; 28(1):57-65. PubMed ID: 15723733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual behavior, attitudes toward safer sex, and gender among a cohort of 244 recovering i.v. drug users.
    Schilling RF; el-Bassel N; Schinke SP; Nichols S; Botvin GJ; Orlandi MA
    Int J Addict; 1991 Aug; 26(8):859-77. PubMed ID: 1960004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 5-year evaluation of a methadone medical maintenance program.
    Harris KA; Arnsten JH; Joseph H; Hecht J; Marion I; Juliana P; Gourevitch MN
    J Subst Abuse Treat; 2006 Dec; 31(4):433-8. PubMed ID: 17084798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Services provided during methadone treatment. A gender comparison.
    Rowan-Szal GA; Chatham LR; Joe GW; Simpson DD
    J Subst Abuse Treat; 2000 Jul; 19(1):7-14. PubMed ID: 10867295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
    Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
    Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid dependence as a chronic disease: the interrelationships between length of stay, methadone dose, and age on treatment outcome at an urban opioid treatment program.
    Kritz S; Chu M; John-Hull C; Madray C; Louie B; Brown LS
    J Addict Dis; 2009; 28(1):53-6. PubMed ID: 19197595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study.
    Gossop M; Marsden J; Stewart D; Lehmann P; Strang J
    Br J Gen Pract; 1999 Jan; 49(438):31-4. PubMed ID: 10622013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of the Weak Opiate Withdrawal Scale for inter-city opiate users.
    Juni S; Hanson M; Ottomanelli G
    Psychol Rep; 1996 Dec; 79(3 Pt 2):1273-4. PubMed ID: 9009777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland's drug and alcohol services.
    Moran L; Keenan E; Elmusharaf K
    BMC Health Serv Res; 2018 Nov; 18(1):911. PubMed ID: 30497467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of psychosocial services in substance abuse treatment.
    McLellan AT; Arndt IO; Metzger DS; Woody GE; O'Brien CP
    JAMA; 1993 Apr; 269(15):1953-9. PubMed ID: 8385230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders.
    Appel PW; Ellison AA; Jansky HK; Oldak R
    Am J Drug Alcohol Abuse; 2004; 30(1):129-53. PubMed ID: 15083558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subjective Quality of Life in opiate-dependent patients before admission after six months and one-year participation in methadone program].
    Habrat B; Chmielewska K; Baran-Furga H; Keszycka B; Taracha E
    Przegl Lek; 2002; 59(4-5):351-4. PubMed ID: 12184005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.